UPDATE: Prometheus Biosciences Inc (RXDX) PT Raised to $60 at Goldman Sachs
Tweet Send to a Friend
(Updated - August 12, 2022 11:37 AM EDT)
Goldman Sachs analyst Chris Shibutani raised the price target on Prometheus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Chris Shibutani raised the price target on Prometheus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
